Paul J. Clancy
2008
In 2008, Paul J. Clancy earned a total compensation of $3.9M as EVP and Chief Financial Officer at Biogen, a 38% increase compared to previous year.
Compensation breakdown
| Bonus | $750,000 |
|---|---|
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $5,321 |
| Non-Equity Incentive Plan | $393,250 |
| Option Awards | $918,891 |
| Salary | $492,308 |
| Stock Awards | $1,250,246 |
| Other | $48,655 |
| Total | $3,858,671 |
Clancy received $1.3M in stock awards, accounting for 32% of the total pay in 2008.
Clancy also received $750K in bonus, $5.3K of change in pension value and nonqualified deferred compensation earnings, $393.3K in non-equity incentive plan, $918.9K in option awards, $492.3K in salary and $48.7K in other compensation.
Rankings
In 2008, Paul J. Clancy's compensation ranked 1,186th out of 9,135 executives tracked by ExecPay. In other words, Clancy earned more than 87.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,186 out of 9,135 | 87th |
Division Manufacturing | 434 out of 3,436 | 87th |
Major group Chemicals And Allied Products | 82 out of 815 | 90th |
Industry group Drugs | 51 out of 597 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 10 out of 118 | 92nd |
Source: SEC filing on April 21, 2011.
Clancy's colleagues
We found three more compensation records of executives who worked with Paul J. Clancy at Biogen in 2008.